{"id":3513,"date":"2026-03-17T10:00:00","date_gmt":"2026-03-17T09:00:00","guid":{"rendered":"https:\/\/www.endotools.be\/?p=3513"},"modified":"2026-03-16T10:56:08","modified_gmt":"2026-03-16T09:56:08","slug":"endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system","status":"publish","type":"post","link":"https:\/\/www.endotools.be\/us-en\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/","title":{"rendered":"Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation\u00a0Endomina\u00ae\u00a0EZFuse\u00a0system\u00a0"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"3513\" class=\"elementor elementor-3513\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-36489fc5 elementor-section-full_width elementor-section-height-min-height elementor-section-height-default elementor-section-items-middle\" data-id=\"36489fc5\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;shape_divider_bottom&quot;:&quot;waves&quot;}\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t<div class=\"elementor-shape elementor-shape-bottom\" aria-hidden=\"true\" data-negative=\"false\">\n\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 1000 100\" preserveAspectRatio=\"none\">\n\t<path class=\"elementor-shape-fill\" d=\"M421.9,6.5c22.6-2.5,51.5,0.4,75.5,5.3c23.6,4.9,70.9,23.5,100.5,35.7c75.8,32.2,133.7,44.5,192.6,49.7\n\tc23.6,2.1,48.7,3.5,103.4-2.5c54.7-6,106.2-25.6,106.2-25.6V0H0v30.3c0,0,72,32.6,158.4,30.5c39.2-0.7,92.8-6.7,134-22.4\n\tc21.2-8.1,52.2-18.2,79.7-24.2C399.3,7.9,411.6,7.5,421.9,6.5z\"\/>\n<\/svg>\t\t<\/div>\n\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-32c7b0f1\" data-id=\"32c7b0f1\" data-element_type=\"column\" data-e-type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-625d2061 elementor-widget elementor-widget-heading\" data-id=\"625d2061\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation Endomina\u00ae EZFuse system <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-505899e elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"505899e\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-c32a83a\" data-id=\"c32a83a\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0188990 elementor-align-left elementor-widget elementor-widget-post-info\" data-id=\"0188990\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"post-info.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul class=\"elementor-inline-items elementor-icon-list-items elementor-post-info\">\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item elementor-repeater-item-b9cc9fe elementor-inline-item\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text elementor-post-info__item elementor-post-info__item--type-custom\">\n\t\t\t\t\t\t\t\t\t\tMarch 17, 2026\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4f9cdd1 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"4f9cdd1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u00a0<\/p><p><em><span class=\"TextRun SCXW87488448 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW87488448 BCX8\">510(k) clearance enables immediate U.S.\u00a0<\/span><span class=\"NormalTextRun SCXW87488448 BCX8\">commercialization of enhanced soft tissue approximation technology<\/span><span class=\"NormalTextRun SCXW87488448 BCX8\">\u00a0<\/span><span class=\"NormalTextRun CommentStart SCXW87488448 BCX8\">in the gastrointestinal tract<\/span><span class=\"NormalTextRun SCXW87488448 BCX8\">\u00a0<\/span><\/span><span class=\"EOP TrackedChange SCXW87488448 BCX8\" data-ccp-props=\"{&quot;335551550&quot;:2,&quot;335551620&quot;:2}\">\u00a0<\/span><\/em><\/p><p><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone size-full wp-image-3515\" src=\"https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/text127-scaled.png\" alt=\"\" width=\"2560\" height=\"1246\" srcset=\"https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/text127-scaled.png 2560w, https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/text127-300x146.png 300w, https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/text127-1024x498.png 1024w, https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/text127-768x374.png 768w, https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/text127-1536x747.png 1536w, https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/text127-2048x997.png 2048w\" sizes=\"(max-width: 2560px) 100vw, 2560px\" \/><\/p><p><span data-contrast=\"auto\"><strong>Gosselies, Belgium \u2013 March 17, 2026 \u2013<\/strong> Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its next-generation technology, the\u00a0endomina\u00ae\u00a0EZFuse\u00a0<\/span><span data-contrast=\"auto\">system<\/span><span data-contrast=\"auto\">. This advancement in the company\u2019s suturing platform\u00a0has been engineered with a more intuitive design\u00a0to deliver\u00a0faster suturing,\u00a0greater efficiency,\u00a0and usability for soft tissue approximation procedures.<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">\u201cThe\u00a0EZFuse\u00a0<\/span><span data-contrast=\"auto\">s<\/span><span data-contrast=\"auto\">ystem<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">clearance\u00a0marks an important milestone in the continued evolution of the\u00a0endomina\u00a0system\u00a0and introduces a number of improvements to\u00a0simplify workflow and\u00a0to\u00a0enhance\u00a0the\u00a0physician experience,\u201d said Alexandre Chau, CEO of Endo Tools Therapeutics. \u201cWe are excited that the new\u00a0system\u00a0is making it easier for physicians to adopt and integrate our device into their practice.\u201d<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">Early procedural experience\u00a0with the next generation\u00a0EZFuse\u00a0<\/span><span data-contrast=\"auto\">system\u00a0<\/span><span data-contrast=\"auto\">demonstrates\u00a0<\/span><span data-contrast=\"auto\">significantly faster\u00a0<\/span><span data-contrast=\"auto\">suturing time<\/span><span data-contrast=\"auto\">,\u00a0<\/span><span data-contrast=\"auto\">with a reduction of\u00a0<\/span><span data-contrast=\"auto\">total procedure time<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">up to\u00a0<\/span><span data-contrast=\"auto\">50%<\/span><span data-contrast=\"auto\">, enabling physicians to complete\u00a0procedures\u00a0more efficiently without changing their established approach.\u00a0<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">The\u00a0<\/span><span data-contrast=\"auto\">suture\u2019s\u00a0<\/span><span data-contrast=\"auto\">single-movement\u00a0<\/span><span data-contrast=\"auto\">mechanism eliminates unnecessary steps, creating a more streamlined workflow. The intuitive design\u00a0reduces staff and operational burden as well as minimizes user fatigue, helping clinical teams perform procedures with greater ease and predictability.\u00a0EZFuse\u00a0<\/span><span data-contrast=\"auto\">suture\u00a0<\/span><span data-contrast=\"auto\">reduces\u00a0complexity across the care setting,\u00a0allowing\u00a0hospitals and ambulatory surgery centers to optimize\u00a0resource utilization, improve scheduling flexibility, and expand overall procedural capacity<\/span><span data-contrast=\"auto\">,\u00a0<\/span><span data-contrast=\"auto\">ultim<\/span><span data-contrast=\"auto\">ately lea<\/span><span data-contrast=\"auto\">ding to\u00a0<\/span><span data-contrast=\"auto\">improved<\/span><span data-contrast=\"auto\">\u00a0patien<\/span><span data-contrast=\"auto\">t care<\/span><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">Denis Gestin,\u00a0Chairman\u00a0of the Board at Endo Tools Therapeutics, added: \u201cETT has always been focused on pushing the boundaries of\u00a0what\u2019s\u00a0possible in endoscopic innovation. With the FDA clearance of\u00a0the next generation\u00a0endomina\u00ae\u00a0EZFuse\u00a0<\/span><span data-contrast=\"auto\">system<\/span><span data-contrast=\"auto\">, we are reinforcing our commitment\u00a0to make advanced endoscopic procedures faster, simpler, and more accessible\u00a0to\u00a0physicians while improving efficiencies for hospitals and ambulatory centers. This milestone positions the company for accelerated growth\u00a0and physician adoption\u00a0in the U.S.\u201d<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">The company will begin commercialization of the\u00a0endomina\u00ae\u00a0EZFuse\u00a0<\/span><span data-contrast=\"auto\">system<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">immediately\u00a0in the U.S., with plans to broaden availability in key markets worldwide.<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p><p><b><span data-contrast=\"auto\">About Endo Tools Therapeutics<\/span><\/b><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p><p><span data-contrast=\"auto\">Located in\u00a0Gosselies, Belgium, Endo Tools Therapeutics S.A. (ETT) offers a portfolio of advanced,\u00a0incisionless\u00a0and minimally invasive endoscopic medical devices. The company\u2019s mission is to develop solutions that expand the range of gastrointestinal procedures that can be performed using standard gastroscopes. By developing minimally invasive treatment solutions, ETT aims to reduce complications and hospital length\u00a0of stay, while improving patient comfort.\u00a0In Europe and select Middle East countries, the devices are approved for endoscopic gastroplasty procedures for the treatment of obesity, with over 1,500\u00a0procedures already performed, while in the U.S. they are cleared for placement of sutures and approximation of soft tissue in the gastrointestinal tract.<\/span><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation Endomina\u00ae EZFuse system \u00a0 510(k) clearance enables immediate U.S.\u00a0commercialization of enhanced soft tissue approximation technology\u00a0in the gastrointestinal tract\u00a0\u00a0 Gosselies, Belgium \u2013 March 17, 2026 \u2013 Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices, today announced that the U.S. Food and Drug Administration (FDA) has [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":3520,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-3513","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-us-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation\u00a0Endomina\u00ae\u00a0EZFuse\u00a0system\u00a0 - endotools<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation\u00a0Endomina\u00ae\u00a0EZFuse\u00a0system\u00a0 - endotools\" \/>\n<meta property=\"og:description\" content=\"Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation Endomina\u00ae EZFuse system \u00a0 510(k) clearance enables immediate U.S.\u00a0commercialization of enhanced soft tissue approximation technology\u00a0in the gastrointestinal tract\u00a0\u00a0 Gosselies, Belgium \u2013 March 17, 2026 \u2013 Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices, today announced that the U.S. Food and Drug Administration (FDA) has [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/\" \/>\n<meta property=\"og:site_name\" content=\"endotools\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-17T09:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/EZFuse.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Theo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Theo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/\"},\"author\":{\"name\":\"Theo\",\"@id\":\"https:\/\/www.endotools.be\/#\/schema\/person\/d3ddbe04085b5660e4d397238bd62fa8\"},\"headline\":\"Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation\u00a0Endomina\u00ae\u00a0EZFuse\u00a0system\u00a0\",\"datePublished\":\"2026-03-17T09:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/\"},\"wordCount\":487,\"publisher\":{\"@id\":\"https:\/\/www.endotools.be\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/EZFuse.png\",\"articleSection\":[\"Uncategorized @us-en\"],\"inLanguage\":\"us-en\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/\",\"url\":\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/\",\"name\":\"Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation\u00a0Endomina\u00ae\u00a0EZFuse\u00a0system\u00a0 - endotools\",\"isPartOf\":{\"@id\":\"https:\/\/www.endotools.be\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/EZFuse.png\",\"datePublished\":\"2026-03-17T09:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#breadcrumb\"},\"inLanguage\":\"us-en\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"us-en\",\"@id\":\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#primaryimage\",\"url\":\"https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/EZFuse.png\",\"contentUrl\":\"https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/EZFuse.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.endotools.be\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation\u00a0Endomina\u00ae\u00a0EZFuse\u00a0system\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.endotools.be\/#website\",\"url\":\"https:\/\/www.endotools.be\/\",\"name\":\"endotools\",\"description\":\"| transoral gastric surgery\",\"publisher\":{\"@id\":\"https:\/\/www.endotools.be\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.endotools.be\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"us-en\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.endotools.be\/#organization\",\"name\":\"Endotools\",\"url\":\"https:\/\/www.endotools.be\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"us-en\",\"@id\":\"https:\/\/www.endotools.be\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/endotools.testing74.8trust.com\/wp-content\/uploads\/2022\/02\/ETT_logo-vectoriel-EPS-NC-20100420.png\",\"contentUrl\":\"https:\/\/endotools.testing74.8trust.com\/wp-content\/uploads\/2022\/02\/ETT_logo-vectoriel-EPS-NC-20100420.png\",\"width\":1363,\"height\":361,\"caption\":\"Endotools\"},\"image\":{\"@id\":\"https:\/\/www.endotools.be\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/endo-tools-therapeutics\/?originalSubdomain=be\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.endotools.be\/#\/schema\/person\/d3ddbe04085b5660e4d397238bd62fa8\",\"name\":\"Theo\",\"url\":\"https:\/\/www.endotools.be\/us-en\/author\/theo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation\u00a0Endomina\u00ae\u00a0EZFuse\u00a0system\u00a0 - endotools","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/","og_locale":"en_US","og_type":"article","og_title":"Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation\u00a0Endomina\u00ae\u00a0EZFuse\u00a0system\u00a0 - endotools","og_description":"Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation Endomina\u00ae EZFuse system \u00a0 510(k) clearance enables immediate U.S.\u00a0commercialization of enhanced soft tissue approximation technology\u00a0in the gastrointestinal tract\u00a0\u00a0 Gosselies, Belgium \u2013 March 17, 2026 \u2013 Endo Tools Therapeutics (ETT), developers of advanced endoscopic medical devices, today announced that the U.S. Food and Drug Administration (FDA) has [&hellip;]","og_url":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/","og_site_name":"endotools","article_published_time":"2026-03-17T09:00:00+00:00","og_image":[{"url":"https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/EZFuse.png","width":1,"height":1,"type":"image\/png"}],"author":"Theo","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Theo","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#article","isPartOf":{"@id":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/"},"author":{"name":"Theo","@id":"https:\/\/www.endotools.be\/#\/schema\/person\/d3ddbe04085b5660e4d397238bd62fa8"},"headline":"Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation\u00a0Endomina\u00ae\u00a0EZFuse\u00a0system\u00a0","datePublished":"2026-03-17T09:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/"},"wordCount":487,"publisher":{"@id":"https:\/\/www.endotools.be\/#organization"},"image":{"@id":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/EZFuse.png","articleSection":["Uncategorized @us-en"],"inLanguage":"us-en"},{"@type":"WebPage","@id":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/","url":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/","name":"Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation\u00a0Endomina\u00ae\u00a0EZFuse\u00a0system\u00a0 - endotools","isPartOf":{"@id":"https:\/\/www.endotools.be\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#primaryimage"},"image":{"@id":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/EZFuse.png","datePublished":"2026-03-17T09:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#breadcrumb"},"inLanguage":"us-en","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/"]}]},{"@type":"ImageObject","inLanguage":"us-en","@id":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#primaryimage","url":"https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/EZFuse.png","contentUrl":"https:\/\/www.endotools.be\/wp-content\/uploads\/2026\/02\/EZFuse.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.endotools.be\/2026\/03\/17\/endo-tools-therapeutics-receives-fda-510k-clearance-for-next-generation-endomina-ezfuse-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.endotools.be\/"},{"@type":"ListItem","position":2,"name":"Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation\u00a0Endomina\u00ae\u00a0EZFuse\u00a0system\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.endotools.be\/#website","url":"https:\/\/www.endotools.be\/","name":"endotools","description":"| transoral gastric surgery","publisher":{"@id":"https:\/\/www.endotools.be\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.endotools.be\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"us-en"},{"@type":"Organization","@id":"https:\/\/www.endotools.be\/#organization","name":"Endotools","url":"https:\/\/www.endotools.be\/","logo":{"@type":"ImageObject","inLanguage":"us-en","@id":"https:\/\/www.endotools.be\/#\/schema\/logo\/image\/","url":"https:\/\/endotools.testing74.8trust.com\/wp-content\/uploads\/2022\/02\/ETT_logo-vectoriel-EPS-NC-20100420.png","contentUrl":"https:\/\/endotools.testing74.8trust.com\/wp-content\/uploads\/2022\/02\/ETT_logo-vectoriel-EPS-NC-20100420.png","width":1363,"height":361,"caption":"Endotools"},"image":{"@id":"https:\/\/www.endotools.be\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/endo-tools-therapeutics\/?originalSubdomain=be"]},{"@type":"Person","@id":"https:\/\/www.endotools.be\/#\/schema\/person\/d3ddbe04085b5660e4d397238bd62fa8","name":"Theo","url":"https:\/\/www.endotools.be\/us-en\/author\/theo\/"}]}},"_links":{"self":[{"href":"https:\/\/www.endotools.be\/us-en\/wp-json\/wp\/v2\/posts\/3513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.endotools.be\/us-en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.endotools.be\/us-en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.endotools.be\/us-en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.endotools.be\/us-en\/wp-json\/wp\/v2\/comments?post=3513"}],"version-history":[{"count":16,"href":"https:\/\/www.endotools.be\/us-en\/wp-json\/wp\/v2\/posts\/3513\/revisions"}],"predecessor-version":[{"id":3554,"href":"https:\/\/www.endotools.be\/us-en\/wp-json\/wp\/v2\/posts\/3513\/revisions\/3554"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.endotools.be\/us-en\/wp-json\/wp\/v2\/media\/3520"}],"wp:attachment":[{"href":"https:\/\/www.endotools.be\/us-en\/wp-json\/wp\/v2\/media?parent=3513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.endotools.be\/us-en\/wp-json\/wp\/v2\/categories?post=3513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.endotools.be\/us-en\/wp-json\/wp\/v2\/tags?post=3513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}